38 related articles for article (PubMed ID: 38752442)
1. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies.
Matsuo K; Kusano A; Sugumar A; Nakamura S; Tajima K; Mueller NE
Cancer Sci; 2004 Sep; 95(9):745-52. PubMed ID: 15471561
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study.
Anderson LA; Gridley G; Engels EA; Morton LM; Cerhan JR; Cozen W; Severson RK; Davis S; Hartge P; Linet MS
Br J Cancer; 2008 Jan; 98(1):161-4. PubMed ID: 18059393
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Nanobiotechnology for the Treatment of Non-Hodgkin's Lymphoma.
Liu S; Xu M; Zhong L; Tong X; Qian S
Mini Rev Med Chem; 2024; 24(9):895-907. PubMed ID: 37724679
[TBL] [Abstract][Full Text] [Related]
4. Age-Related Disease Risks in Younger versus Older B-Cell Non-Hodgkin's Lymphoma Survivors.
Ocier K; Abdelaziz S; Kim S; Rowe K; Snyder J; Deshmukh VG; Newman M; Fraser A; Smith KR; Porucznik CA; Shoaf K; Stanford JB; Lee CJ; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2268-2277. PubMed ID: 34732401
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Expression and Its Correlation with PD-L1 Expression in Non-Hodgkin's Lymphoma and Hodgkin's Lymphoma at Dr. Saiful Anwar Regional Public Hospital in Malang, Indonesian Population.
Hambalie AO; Norahmawati E; Endharti AT; Retnani DP; Rahmadiani N
Adv Hematol; 2024; 2024():7989996. PubMed ID: 38817669
[TBL] [Abstract][Full Text] [Related]
6. Variation in guideline adherence in non-Hodgkin's lymphoma care: impact of patient and hospital characteristics.
Stienen JJ; Hermens RP; Wennekes L; van de Schans SA; van der Maazen RW; Dekker HM; Liefers J; van Krieken JH; Blijlevens NM; Ottevanger PB;
BMC Cancer; 2015 Aug; 15():578. PubMed ID: 26253203
[TBL] [Abstract][Full Text] [Related]
7. Birth order and risk of non-hodgkin lymphoma--true association or bias?
Grulich AE; Vajdic CM; Falster MO; Kane E; Smedby KE; Bracci PM; de Sanjose S; Becker N; Turner J; Martinez-Maza O; Melbye M; Engels EA; Vineis P; Costantini AS; Holly EA; Spinelli JJ; La Vecchia C; Zheng T; Chiu BC; Franceschi S; Cocco P; Maynadié M; Foretova L; Staines A; Brennan P; Davis S; Severson RK; Cerhan JR; Breen EC; Birmann B; Cozen W
Am J Epidemiol; 2010 Sep; 172(6):621-30. PubMed ID: 20720098
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions.
Högfeldt T; Jaing C; Loughlin KM; Thissen J; Gardner S; Bahnassy AA; Gharizadeh B; Lundahl J; Österborg A; Porwit A; Zekri AN; Khaled HM; Mellstedt H; Moshfegh A
Oncol Lett; 2016 Oct; 12(4):2782-2788. PubMed ID: 27698858
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018-2022): A real-world, retrospective study.
Li Z; Guo W; Zhao Y; Wang H; Guo J; Li Z; Wang B; Cao L; Xu J; Young KH; Bai O
Cancer Med; 2024 May; 13(10):e7284. PubMed ID: 38752442
[TBL] [Abstract][Full Text] [Related]
10. The impact of hepatitis B virus and hepatitis C virus infections in patients with Hodgkin's and non-Hodgkin's lymphoma.
Kadry DY; Elbahnasawy MA; Mansour MT; El Gebaly OK; Aziz H; Kamel MM; Abdel-Moneim AS; Radwan S
Int J Immunopathol Pharmacol; 2023; 37():3946320231207342. PubMed ID: 37859403
[TBL] [Abstract][Full Text] [Related]
11. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
12. Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study.
Lai YR; Chang YL; Lee CH; Tsai TH; Huang KH; Lee CY
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158850
[TBL] [Abstract][Full Text] [Related]
13. NK-/T-cell lymphomas.
Wang H; Fu BB; Gale RP; Liang Y
Leukemia; 2021 Sep; 35(9):2460-2468. PubMed ID: 34117356
[TBL] [Abstract][Full Text] [Related]
14. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020.
Cao W; Chen HD; Yu YW; Li N; Chen WQ
Chin Med J (Engl); 2021 Mar; 134(7):783-791. PubMed ID: 33734139
[TBL] [Abstract][Full Text] [Related]
15. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
Li M; Shen Y; Chen Y; Gao H; Zhou J; Wang Q; Fan C; Zhang W; Li J; Cong H; Gu J; Gan Y; Tu H
Int J Cancer; 2020 Oct; 147(8):2199-2209. PubMed ID: 32350851
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Surface Antigen Positivity Is an Independent Unfavorable Prognostic Factor in Diffuse Large B-Cell Lymphoma in the Rituximab Era.
Cheng CL; Huang SC; Chen JH; Wei CH; Fang WQ; Su TH; Yuan CT; Liu JH; Chuang MK; Tien HF
Oncologist; 2020 Sep; 25(9):793-802. PubMed ID: 32275807
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B virus infection is associated with a poorer prognosis in diffuse large B-cell lymphoma: a meta-analysis and systemic review.
Rong X; Wang H; Ma J; Pan S; Wang H; Jing S; Su Y; Wang L; Zhao C
J Cancer; 2019; 10(15):3450-3458. PubMed ID: 31293649
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
